PubMed HealthSearch

PubMed · 5383911

[Vaso-active substances].

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

1969. [Vaso-active substances].. https://pubmed.ncbi.nlm.nih.gov/5383911/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Quantitation of catecholamines in uninflamed human dental pulp tissues by high-performance liquid chromatography.

The quantitation of catecholamines has yet to be reported in the human dental pulp. Various methods of chemical detection have shown the presence of catecholamines in pulpal tissue. Pulpal tissue was obtained from nonrestored, uninflamed teeth that needed to be extracted. The samples were collected, extracted, and analyzed by means of high-performance liquid chromatography with ultraviolet detection for levels of catecholamines (dopamine, epinephrine, and norepinephrine). As mediators of vasoconstriction, catecholamines play an important role in the control of intrapulpal pressure. This research describes a method for quantitation of catecholamines. Future studies investigating inflamed tissue can now be accomplished with the use of this analytic method. The results from this research indicate a baseline level of catecholamines in the uninflamed human dental pulp.

Catecholamines

Glucose metabolism and liver cirrhosis.

Chronic liver disease is characterized by numerous metabolic alterations, predominantly catabolic, resulting in the clinical picture of malnutrition and even cachexia in some patients. The following review focuses on disturbances of glucose metabolism and of hormonal interactions that could contribute to the clinical picture of malnutrition seen in chronic liver disease. Body composition is altered in a characteristic manner with an increase in fat mass and a significant loss of muscle tissue. Furthermore, defective glucose storage due to reduced insulin sensitivity predominantly of muscle tissue has been observed. The pathogenesis of insulin resistance leading to an impaired glucose tolerance or a manifest diabetes mellitus is as yet unknown. A receptor/postreceptor dysfunction probably exists in chronic liver disease that might be explained by the following factors: 1. Altered membrane lipid composition and increased levels of free fatty acids; 2. long-lasting hyperinsulinemia; 3. increased plasma levels of insulin counteracting hormones such as growth hormone, glucagon, catecholamines and possibly cytokines; 4. a lack of liver-derived humoral factors with insulin-like activity, i.e. insulin-like growth factors I and II.

Catecholamines